BioSpace News Archive

NextVein LLC announced a breakthrough product that makes vein visualization affordable for every clinician.

Valent BioSciences LLC and Kansas State University, Manhattan, Kansas, announce a formal long-term agreement to advance critical research in the areas of soil health and carbon smart farming. Kansas State University Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice, a world-renowned researcher in carbon cycling and climate change, will oversee this initiative.

Global Coalition for Adaptive Research (GCAR) announces a new clinical trial initiative, Ovarian CanceRx™.

Today, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has released its final report

SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), today announced the peer-reviewed publication of a new microscopy-based epitranscriptomic method powered by SeqLL’s tSMS platform in the August issue of Cell Report Methods.

BlackOxygen Organcs is recalling all lots of BlackOxygen Tablets and BlackOxygen Organics Powder due to potential health risks.

ValnevaSE, a specialty vaccine company, announced that it has commenced recruitment of adolescents in its pivotal Phase 3 Clinical Trial for its inactivated COVID-19 vaccine candidate VLA2001 in the United Kingdom.

Diadem srl announced release of a new publication, Post-Translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease, that reviews how post-translational modifications of the p53 protein may impact the development of Alzheimer’s disease.

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy, will report positive 1.5-year functional data and patient-reported outcome measures for Patients 4-6 in the ongoing IGNITE DMD Phase I/II clinical trial of SGT-001.

Global health service company Cigna Corporation announced several new leadership roles and positions to drive accelerated growth across its diverse business portfolio.